- Home
- LDP vs TLRY Comparison
LDP vs TLRY Comparison
Compare LDP & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDP
- TLRY
- Stock Information
- Founded
- LDP 2012
- TLRY N/A
- Country
- LDP United States
- TLRY Canada
- Employees
- LDP N/A
- TLRY N/A
- Industry
- LDP Finance Companies
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- LDP Finance
- TLRY Health Care
- Exchange
- LDP Nasdaq
- TLRY Nasdaq
- Market Cap
- LDP 613.9M
- TLRY 624.7M
- IPO Year
- LDP N/A
- TLRY 2018
- Fundamental
- Price
- LDP $21.18
- TLRY $1.03
- Analyst Decision
- LDP
- TLRY Hold
- Analyst Count
- LDP 0
- TLRY 3
- Target Price
- LDP N/A
- TLRY $1.38
- AVG Volume (30 Days)
- LDP 102.5K
- TLRY 78.6M
- Earning Date
- LDP 01-01-0001
- TLRY 10-09-2025
- Dividend Yield
- LDP 7.91%
- TLRY N/A
- EPS Growth
- LDP N/A
- TLRY N/A
- EPS
- LDP N/A
- TLRY N/A
- Revenue
- LDP N/A
- TLRY $821,309,000.00
- Revenue This Year
- LDP N/A
- TLRY $8.95
- Revenue Next Year
- LDP N/A
- TLRY $4.76
- P/E Ratio
- LDP N/A
- TLRY N/A
- Revenue Growth
- LDP N/A
- TLRY 4.10
- 52 Week Low
- LDP $16.16
- TLRY $0.35
- 52 Week High
- LDP $20.30
- TLRY $1.98
- Technical
- Relative Strength Index (RSI)
- LDP 48.49
- TLRY 64.74
- Support Level
- LDP $20.93
- TLRY $0.55
- Resistance Level
- LDP $21.55
- TLRY $1.37
- Average True Range (ATR)
- LDP 0.16
- TLRY 0.12
- MACD
- LDP -0.03
- TLRY 0.05
- Stochastic Oscillator
- LDP 37.31
- TLRY 58.54
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.